Evaluation of Phenobarbital Serum Levels on Clinical Outcomes for the Treatment of Severe Alcohol Withdrawal Syndrome in a Medical Intensive Care Unit

Key Points

• This research investigates the relationship between phenobarbital serum levels and clinical outcomes in severe alcohol withdrawal syndrome (AWS).
• Evaluated patients admitted to a medical intensive care unit (MICU) for severe AWS.
• Analyzed serum levels of phenobarbital in relation to symptom control.
• No significant association between phenobarbital serum levels and symptom control was identified.
• Findings suggest that serum levels may not correlate with clinical outcomes in severe alcohol withdrawal.